cannabis investing MediPharm Labs Assembles Globally Renowned Experts to Form Scientific Advisory Committee
cannabis investing MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million
cannabis investing MediPharm Labs Acquires Over 5,000 KG of Dried Cannabis for Private Label Cannabis Oil Production and Launches New White Label Solutions Platform
cannabis investing MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results
cannabis investing MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences
